Literature DB >> 26799785

A new HIF-1α/RANTES-driven pathway to hepatocellular carcinoma mediated by germline haploinsufficiency of SART1/HAF in mice.

Mei Yee Koh1, Mihai Gagea2, Timothy Sargis1, Robert Lemos1, Geoffrey Grandjean1, Adriana Charbono1, Vasileos Bekiaris1, John Sedy1, Galina Kiriakova2, Xiuping Liu2, Lewis R Roberts3, Carl Ware1, Garth Powis1.   

Abstract

UNLABELLED: The hypoxia-inducible factor (HIF), HIF-1, is a central regulator of the response to low oxygen or inflammatory stress and plays an essential role in survival and function of immune cells. However, the mechanisms regulating nonhypoxic induction of HIF-1 remain unclear. Here, we assess the impact of germline heterozygosity of a novel, oxygen-independent ubiquitin ligase for HIF-1α: hypoxia-associated factor (HAF; encoded by SART1). SART1(-/-) mice were embryonic lethal, whereas male SART1(+/-) mice spontaneously recapitulated key features of nonalcoholic steatohepatitis (NASH)-driven hepatocellular carcinoma (HCC), including steatosis, fibrosis, and inflammatory cytokine production. Male, but not female, SART1(+/-) mice showed significant up-regulation of HIF-1α in circulating and liver-infiltrating immune cells, but not in hepatocytes, before development of malignancy. Additionally, Kupffer cells derived from male, but not female, SART1(+/-) mice produced increased levels of the HIF-1-dependent chemokine, regulated on activation, normal T-cell expressed and secreted (RANTES), compared to wild type. This was associated with increased liver-neutrophilic infiltration, whereas infiltration of lymphocytes and macrophages were not significantly different. Neutralization of circulating RANTES decreased liver neutrophilic infiltration and attenuated HCC tumor initiation/growth in SART1(+/-) mice.
CONCLUSION: This work establishes a new tumor-suppressor role for HAF in immune cell function by preventing inappropriate HIF-1 activation in male mice and identifies RANTES as a novel therapeutic target for NASH and NASH-driven HCC.
© 2016 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26799785      PMCID: PMC4840057          DOI: 10.1002/hep.28468

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

1.  The 65 and 110 kDa SR-related proteins of the U4/U6.U5 tri-snRNP are essential for the assembly of mature spliceosomes.

Authors:  O V Makarova; E M Makarov; R Lührmann
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

2.  HIF-1alpha is essential for myeloid cell-mediated inflammation.

Authors:  Thorsten Cramer; Yuji Yamanishi; Björn E Clausen; Irmgard Förster; Rafal Pawlinski; Nigel Mackman; Volker H Haase; Rudolf Jaenisch; Maripat Corr; Victor Nizet; Gary S Firestein; Hans Peter Gerber; Napoleone Ferrara; Randall S Johnson
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 3.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 4.  Activation of the HIF pathway in cancer.

Authors:  P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Curr Opin Genet Dev       Date:  2001-06       Impact factor: 5.578

5.  Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation.

Authors:  P Jaakkola; D R Mole; Y M Tian; M I Wilson; J Gielbert; S J Gaskell; A von Kriegsheim; H F Hebestreit; M Mukherji; C J Schofield; P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Science       Date:  2001-04-05       Impact factor: 47.728

6.  Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation.

Authors:  Georgi Kirovski; Erwin Gäbele; Christoph Dorn; Lukas Moleda; Christoph Niessen; Thomas S Weiss; Hella Wobser; Doris Schacherer; Christa Buechler; Hermann E Wasmuth; Claus Hellerbrand
Journal:  Int J Clin Exp Pathol       Date:  2010-08-02

7.  Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES.

Authors:  T J Schall; K Bacon; K J Toy; D V Goeddel
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

8.  Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.

Authors:  V H Haase; J N Glickman; M Socolovsky; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

9.  Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production.

Authors:  Willscott E Naugler; Toshiharu Sakurai; Sunhwa Kim; Shin Maeda; Kyounghyun Kim; Ahmed M Elsharkawy; Michael Karin
Journal:  Science       Date:  2007-07-06       Impact factor: 47.728

10.  Acyl-CoA synthetase mRNA expression is controlled by fibric-acid derivatives, feeding and liver proliferation.

Authors:  K Schoonjans; B Staels; P Grimaldi; J Auwerx
Journal:  Eur J Biochem       Date:  1993-09-01
View more
  16 in total

Review 1.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

2.  Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.

Authors:  Jian Jin; Banrida Wahlang; Hongxue Shi; Josiah E Hardesty; K Cameron Falkner; Kimberly Z Head; Sudhir Srivastava; Michael L Merchant; Shesh N Rai; Matthew C Cave; Russell A Prough
Journal:  Med Chem Res       Date:  2020-06-07       Impact factor: 1.965

Review 3.  Hypoxia-inducible factors and innate immunity in liver cancer.

Authors:  Vincent Wai-Hin Yuen; Carmen Chak-Lui Wong
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 4.  Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells.

Authors:  Benjamin Ruf; Bernd Heinrich; Tim F Greten
Journal:  Cell Mol Immunol       Date:  2020-11-24       Impact factor: 11.530

Review 5.  Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities.

Authors:  Yankai Wen; Joeri Lambrecht; Cynthia Ju; Frank Tacke
Journal:  Cell Mol Immunol       Date:  2020-10-12       Impact factor: 11.530

6.  Expression of Interferon Effector Gene SART1 Correlates with Interferon Treatment Response against Hepatitis B Infection.

Authors:  Yong Li; Chuanlong Zhu; Faxi Wang; Tiantian Zhu; Jun Li; Shufeng Liu; Fei Xiao
Journal:  Mediators Inflamm       Date:  2016-12-18       Impact factor: 4.711

7.  C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.

Authors:  Ying Zhu; Xiao-Mei Gao; Jing Yang; Da Xu; Yu Zhang; Ming Lu; Ze Zhang; Yuan-Yuan Sheng; Jian-Hua Li; Xin-Xin Yu; Yan Zheng; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cancer Sci       Date:  2018-02-13       Impact factor: 6.716

8.  Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell-Mediated Hepatitis via Compensatory Up-regulation of CXCR2-Related Chemokine Activity.

Authors:  Lili Chen; Jinyang Gu; Yihan Qian; Meng Li; Yongbing Qian; Min Xu; Jichang Li; Yankai Wen; Lei Xia; Jiaxin Li; Qiang Xia; Xiaoni Kong; Hailong Wu
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2019-01-07

Review 9.  Recent Insight into the Role of Fibrosis in Nonalcoholic Steatohepatitis-Related Hepatocellular Carcinoma.

Authors:  Antonio Sircana; Elena Paschetta; Francesca Saba; Federica Molinaro; Giovanni Musso
Journal:  Int J Mol Sci       Date:  2019-04-09       Impact factor: 5.923

Review 10.  Tumor Immune Microenvironment and Immunosuppressive Therapy in Hepatocellular Carcinoma: A Review.

Authors:  Kyoko Oura; Asahiro Morishita; Joji Tani; Tsutomu Masaki
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.